NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Total Liabilities (2020 - 2025)

NeuroSense Therapeutics' (NRSN) quarterly Total Liabilities came in at $2.6 million in Q4 2025, up 29.92% year-over-year from $2.0 million in Q4 2024, and up 17.48% quarter-over-quarter from $2.2 million in Q2 2025.

Analysis

NeuroSense Therapeutics (NRSN) Total Liabilities (2020 - 2025) Analysis & Trends

NeuroSense Therapeutics has disclosed Total Liabilities across 6 years of filings, most recently posting $2.6 million for Q4 2025.

  • In Q4 2025, Total Liabilities rose 29.92% year-over-year to $2.6 million; the TTM figure through Dec 2025 stood at $2.6 million (up 29.92% YoY), while the FY2025 annual figure was $2.6 million, up 29.92% from the prior year.
  • Total Liabilities came in at $2.6 million for Q4 2025 at NeuroSense Therapeutics, up from $2.2 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $9.4 million in Q2 2023 to a low of $1.4 million in Q3 2022.
  • Average Total Liabilities over 5 years is $3.6 million, with a median of $2.4 million recorded in 2023.
  • Year-over-year, Total Liabilities jumped 1920.83% in 2021 and plunged 62.35% in 2024.
  • Over 5 years, Total Liabilities stood at $2.4 million in 2021, then declined by 22.76% to $1.9 million in 2022, then soared by 163.96% to $4.9 million in 2023, then slumped by 59.71% to $2.0 million in 2024, then climbed by 29.92% to $2.6 million in 2025.
  • Per Business Quant data, the three most recent Total Liabilities figures were $2.6 million in Q4 2025, $2.2 million in Q2 2025, and $2.0 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 83.95 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 37.53 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 7.18 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 10.02 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 4.20 Bn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 1.62 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 4.20 Bn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn 13.24 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn 384.62 Mn
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn - 2.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.59 Mn
Jun 30, 2025 2.20 Mn
Dec 31, 2024 1.99 Mn
Sep 30, 2024 3.80 Mn
Jun 30, 2024 3.54 Mn
Mar 31, 2024 8.44 Mn
Dec 31, 2023 4.94 Mn
Sep 30, 2023 5.58 Mn
Jun 30, 2023 9.41 Mn
Mar 31, 2023 2.45 Mn
Dec 31, 2022 1.87 Mn
Sep 30, 2022 1.38 Mn
Jun 30, 2022 1.62 Mn
Mar 31, 2022 2.25 Mn
Dec 31, 2021 2.43 Mn
Dec 31, 2020 120,000.00
API Access

NeuroSense Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=NRSN&period=max&api_key=YOUR_API_KEY